Published in J Neurosci on March 26, 2014
Developing treatments for cognitive deficits in schizophrenia: the challenge of translation. J Psychopharmacol (2014) 1.04
Translational Rodent Paradigms to Investigate Neuromechanisms Underlying Behaviors Relevant to Amotivation and Altered Reward Processing in Schizophrenia. Schizophr Bull (2015) 0.93
The neural basis of reversal learning: An updated perspective. Neuroscience (2016) 0.91
Temporal Specificity of Reward Prediction Errors Signaled by Putative Dopamine Neurons in Rat VTA Depends on Ventral Striatum. Neuron (2016) 0.83
Amygdala and Ventral Striatum Make Distinct Contributions to Reinforcement Learning. Neuron (2016) 0.83
Pedunculopontine tegmental nucleus lesions impair probabilistic reversal learning by reducing sensitivity to positive reward feedback. Neurobiol Learn Mem (2016) 0.79
Neural networks supporting switching, hypothesis testing, and rule application. Neuropsychologia (2015) 0.76
Cerebellar contribution to higher and lower order rule learning and cognitive flexibility in mice. Neuroscience (2016) 0.75
Dissociable effects of NR2A and NR2B NMDA receptor antagonism on cognitive flexibility but not pattern separation. Psychopharmacology (Berl) (2015) 0.75
CACNA1C gene regulates behavioral strategies in operant rule learning. PLoS Biol (2017) 0.75
Ketamine decreases sensitivity of male rats to misleading negative feedback in a probabilistic reversal-learning task. Psychopharmacology (Berl) (2016) 0.75
Ventral Striatum Lesions Do Not Affect Reinforcement Learning With Deterministic Outcomes on Slow Time Scales. Behav Neurosci (2017) 0.75
Effects of ventral striatum lesions on stimulus versus action based reinforcement learning. J Neurosci (2017) 0.75
Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci (2007) 4.98
Abrupt transitions between prefrontal neural ensemble states accompany behavioral transitions during rule learning. Neuron (2010) 2.46
Nucleus accumbens long-term depression and the expression of behavioral sensitization. Science (2005) 2.26
Dopaminergic modulation of risk-based decision making. Neuropsychopharmacology (2008) 2.18
Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci (2009) 2.02
Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids. Nat Neurosci (2013) 1.73
Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry (2010) 1.57
Thalamic-prefrontal cortical-ventral striatal circuitry mediates dissociable components of strategy set shifting. Cereb Cortex (2006) 1.53
Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology (2009) 1.47
Dissociable contributions by prefrontal D1 and D2 receptors to risk-based decision making. J Neurosci (2011) 1.45
Ventral striatal dopamine modulation of different forms of behavioral flexibility. Neuropsychopharmacology (2009) 1.45
Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task. J Neurosci (2004) 1.41
Reducing prefrontal gamma-aminobutyric acid activity induces cognitive, behavioral, and dopaminergic abnormalities that resemble schizophrenia. Biol Psychiatry (2010) 1.40
Hippocampal long-term depression is required for the consolidation of spatial memory. Proc Natl Acad Sci U S A (2010) 1.39
Prefrontal cortical contribution to risk-based decision making. Cereb Cortex (2009) 1.38
Separate prefrontal-subcortical circuits mediate different components of risk-based decision making. J Neurosci (2012) 1.36
Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res (2002) 1.36
Fundamental contribution by the basolateral amygdala to different forms of decision making. J Neurosci (2009) 1.34
Disruption of AMPA receptor endocytosis impairs the extinction, but not acquisition of learned fear. Neuropsychopharmacology (2007) 1.30
Interaction between perirhinal and medial prefrontal cortex is required for temporal order but not recognition memory for objects in rats. J Neurosci (2004) 1.30
Differential effects of inactivation of the orbitofrontal cortex on strategy set-shifting and reversal learning. Neurobiol Learn Mem (2007) 1.27
Differential effects on effort discounting induced by inactivations of the nucleus accumbens core or shell. Behav Neurosci (2010) 1.27
Hippocampal long-term depression mediates acute stress-induced spatial memory retrieval impairment. Proc Natl Acad Sci U S A (2007) 1.26
Modulation by central and basolateral amygdalar nuclei of dopaminergic correlates of feeding to satiety in the rat nucleus accumbens and medial prefrontal cortex. J Neurosci (2002) 1.24
Contributions of the nucleus accumbens and its subregions to different aspects of risk-based decision making. Cogn Affect Behav Neurosci (2011) 1.24
Contributions of the orbitofrontal cortex to impulsive choice: interactions with basal levels of impulsivity, dopamine signalling, and reward-related cues. Psychopharmacology (Berl) (2010) 1.23
Glutamate receptor-dependent modulation of dopamine efflux in the nucleus accumbens by basolateral, but not central, nucleus of the amygdala in rats. J Neurosci (2002) 1.21
Differential effects of dopaminergic manipulations on risky choice. Psychopharmacology (Berl) (2010) 1.21
Glucocorticoid receptors in the prefrontal cortex regulate stress-evoked dopamine efflux and aspects of executive function. Proc Natl Acad Sci U S A (2011) 1.18
A 'crash' course on psychostimulant withdrawal as a model of depression. Trends Pharmacol Sci (2002) 1.16
Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry (2005) 1.11
NMDA GluN2A and GluN2B receptors play separate roles in the induction of LTP and LTD in the amygdala and in the acquisition and extinction of conditioned fear. Neuropharmacology (2011) 1.11
Electrophysiological interactions between striatal glutamatergic and dopaminergic systems. Ann N Y Acad Sci (2003) 1.08
Blockade of NMDA GluN2B receptors selectively impairs behavioral flexibility but not initial discrimination learning. Psychopharmacology (Berl) (2011) 1.05
Receptor-specific modulation of risk-based decision making by nucleus accumbens dopamine. Neuropsychopharmacology (2012) 1.03
Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates. Psychopharmacology (Berl) (2004) 1.02
Selective involvement by the medial orbitofrontal cortex in biasing risky, but not impulsive, choice. Cereb Cortex (2012) 1.00
Systemic and local administration of estradiol into the prefrontal cortex or hippocampus differentially alters working memory. Neurobiol Learn Mem (2006) 0.99
Chronic alcohol disrupts dopamine receptor activity and the cognitive function of the medial prefrontal cortex. J Neurosci (2014) 0.99
Acute stress induces selective alterations in cost/benefit decision-making. Neuropsychopharmacology (2012) 0.99
Dynamic fluctuations in dopamine efflux in the prefrontal cortex and nucleus accumbens during risk-based decision making. J Neurosci (2012) 0.98
Abnormalities of presynaptic protein CDCrel-1 in striatum of rats reared in social isolation: relevance to neural connectivity in schizophrenia. Eur J Neurosci (2004) 0.96
Estradiol modulates effort-based decision making in female rats. Neuropsychopharmacology (2011) 0.96
Neurochemical correlates of relapse to d-amphetamine self-administration by rats induced by stimulation of the ventral subiculum. Psychopharmacology (Berl) (2003) 0.96
Measuring the construct of executive control in schizophrenia: defining and validating translational animal paradigms for discovery research. Neurosci Biobehav Rev (2012) 0.95
Prevention of LPS-induced microglia activation, cytokine production and sickness behavior with TLR4 receptor interfering peptides. PLoS One (2013) 0.94
Dopamine efflux in the nucleus accumbens during within-session extinction, outcome-dependent, and habit-based instrumental responding for food reward. Psychopharmacology (Berl) (2006) 0.92
Exposure to repeated, intermittent d-amphetamine induces sensitization of HPA axis to a subsequent stressor. Neuropsychopharmacology (2002) 0.91
Increased successive negative contrast in rats withdrawn from an escalating-dose schedule of D-amphetamine. Pharmacol Biochem Behav (2002) 0.90
Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists. Psychopharmacology (Berl) (2006) 0.90
Attenuated dopamine efflux in the rat nucleus accumbens during successive negative contrast. Behav Neurosci (2004) 0.90
Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.90
Processing efficiency of a verbal working memory system is modulated by amphetamine: an fMRI investigation. Psychopharmacology (Berl) (2005) 0.89
Emerging, reemerging, and forgotten brain areas of the reward circuit: Notes from the 2010 Motivational Neural Networks conference. Behav Brain Res (2011) 0.88
Tracking progress toward a goal in corticostriatal ensembles. J Neurosci (2014) 0.85
Inhibition of dopamine efflux in the rat nucleus accumbens during abstinence after free access to d-amphetamine. Behav Brain Res (2002) 0.84
Repeated amphetamine exposure disrupts dopaminergic modulation of amygdala-prefrontal circuitry and cognitive/emotional functioning. J Neurosci (2011) 0.84
Kindling of basolateral amygdala but not ventral hippocampus or perirhinal cortex disrupts sensorimotor gating in rats. Behav Brain Res (2006) 0.84
Interleukin 1 beta enhances conditioned fear memory in rats: possible involvement of glucocorticoids. Eur J Neurosci (2003) 0.83
Ventral hippocampal involvement in temporal order, but not recognition, memory for spatial information. Hippocampus (2008) 0.83
Neural circuits engaged in ventral hippocampal modulation of dopamine function in medial prefrontal cortex and ventral striatum. Brain Struct Funct (2008) 0.82
Selective effects of typical antipsychotic drugs on SNAP-25 and synaptophysin in the hippocampal trisynaptic pathway. Int J Neuropsychopharmacol (2005) 0.82
Block of voltage-gated calcium channels stimulates dopamine efflux in rat mesocorticolimbic system. Neuropharmacology (2009) 0.81
Tolerance to the anhedonic effects of lipopolysaccharide is associated with changes in syntaxin immunoreactivity in the nucleus accumbens. Int J Neuropsychopharmacol (2003) 0.81
Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats. Eur J Neurosci (2004) 0.80
A preclinical assessment of d.l-govadine as a potential antipsychotic and cognitive enhancer. Int J Neuropsychopharmacol (2011) 0.80
Noradrenergic modulation of risk/reward decision making. Psychopharmacology (Berl) (2015) 0.79
Glucocorticoid receptors in the prefrontal cortex regulate dopamine efflux to stress via descending glutamatergic feedback to the ventral tegmental area. Int J Neuropsychopharmacol (2013) 0.79
Prenatal ethanol exposure in rats decreases levels of complexin proteins in the frontal cortex. Alcohol Clin Exp Res (2005) 0.79
Electrical stimulation of the hippocampus disrupts prepulse inhibition in rats: frequency- and site-dependent effects. Behav Brain Res (2004) 0.79
Multifaceted Contributions by Different Regions of the Orbitofrontal and Medial Prefrontal Cortex to Probabilistic Reversal Learning. J Neurosci (2016) 0.78
Repeated cycles of restricted food intake and binge feeding disrupt sensory-specific satiety in the rat. Behav Brain Res (2012) 0.77
Repeated electroconvulsive shock attenuates the depressive-like effects of d-amphetamine withdrawal on brain reward function in rats. Psychopharmacology (Berl) (2001) 0.76
Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucrose-evoked dopamine efflux in the rat nucleus accumbens. Neuropsychopharmacology (2006) 0.76
A waitlist control-group study of cognitive, mood, and quality of life outcome after posteroventral pallidotomy in Parkinson disease. J Neurosurg (2003) 0.76
Stability of avoidance behaviour following repeated intermittent treatment with clozapine, olanzapine or D,L-govadine. Behav Pharmacol (2015) 0.76
Daily monitoring of dopamine efflux reveals a short-lasting occlusion of the dopamine agonist properties of d-amphetamine by dopamine transporter blockers GBR 12909 and methylphenidate. ACS Chem Neurosci (2013) 0.76